Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance.
- NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_assertion description "[CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance.
- NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_assertion evidence source_evidence_literature NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance.
- NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_assertion SIO_000772 23414588 NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance.
- NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_assertion wasDerivedFrom befree-20140225 NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance.
- NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_assertion wasGeneratedBy ECO_0000203 NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP850637.RA9___jDNcPWrhXFJF7OgR2_Mc5qT-GJq5IJfXkZXX5wE130_provenance.